🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Fischer Medical Ventures Limited FISCHER NSEPHARMA

Healthcare · Medical Devices · India
https://www.fischermv.com

Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. Its product portfolio includes magnetic resonance imaging (MRI) systems; preventive health kiosks; e-health access points; software solutions; cancer, TB screening, and handheld x-ray; spincare technology; nutraceuticals from plant extracts; mental health solutions; contactless screening solutions; and CT scan systems, as well as preventive diagnostic devices and ancillary medical instruments. The company was formerly known as Fischer Chemic Limited and changed its name to Fischer Medical Ventures Limited in March 2024. Fischer Medical Ventures Limited was incorporated in 1993 and is headquartered in Chennai, India.

READ MORE ›
₹38.14
-50.84% 1Y

Market & Price

Market Cap
₹2,496.32 Cr
Current Price
₹38.14
High / Low (52W)
₹117.71 / ₹33.20
Beta
-0.13

Valuation

Stock P/E
64.64
Industry PE
37.60
Forward P/E
-
PEG Ratio
-
Book Value
₹5.57
Price to Book
6.85
P/S
9.60
EV/EBITDA
56.58
Dividend Yield
0.01%

Profitability & Returns

ROCE
0.74%
ROE
-
ROA
-
Profit Margin
15.17%
Op Margin
20.57%
EPS (Latest Qtr)
₹0.29
EPS (TTM)
₹0.59

Balance Sheet & Liquidity

Debt/Equity
0.10
Quick Ratio
-
Current Ratio
-
Debt
₹37.01 Cr
Total Assets
₹457.37 Cr
Current Assets
₹365.29 Cr
Working Capital
₹263.47 Cr

Ownership

Promoter Holding
76.28%
Chg in Prom Hold
-
FII / Inst Holding
2.55%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹2,440.16 Cr
Total Revenue (TTM)
₹260.02 Cr
EBITDA
₹43.13 Cr
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
₹65.45 Cr
Gross Margin
36.91%
Payout Ratio
0.85%

Growth (CAGR)

Revenue 5Y
-
Profit 5Y
206.43%
Revenue (YoY)
760.50%
Earnings (YoY)
-

PROS

  • Profit CAGR of 206.4% over 5 years.

CONS

  • Trading at a high P/E of 64.6.
  • Trading 67.6% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 FISCHER Fischer Medical Ventures Limited NSEPHARMA 38.14 64.64 ₹2,496.32 Cr 0.01% 0.74% - - 206.43%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
⚙Ad space

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Dec 2025
Revenue 39.66 Cr11.75 Cr49.17 Cr23.44 Cr101.10 Cr
Cost of Revenue 36.13 Cr7.54 Cr39.31 Cr12.76 Cr50.17 Cr
Gross Profit 3.53 Cr4.21 Cr9.86 Cr10.68 Cr50.93 Cr
Operating Expenses 3.32 Cr4.27 Cr6.49 Cr7.19 Cr30.13 Cr
Operating Income 20.58 L-6.11 L3.37 Cr3.49 Cr20.79 Cr
EBITDA 54.69 L74.84 L2.48 Cr11.61 Cr22.60 Cr
Interest Expense 4.86 L6.69 L16.20 L66.99 L63.71 L
Pretax Income 21.02 L12.44 L1.81 Cr10.18 Cr21.19 Cr
Tax Provision -8.31 L41.83 L49.99 L5.17 Cr1.95 Cr
Net Income 29.33 L-29.39 L1.31 Cr5.01 Cr19.23 Cr
Diluted EPS 0.05-0.01-0.010.29

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Revenue 017.95 L20.98 Cr110.70 Cr
Cost of Revenue -016.45 Cr91.59 Cr
Gross Profit -17.95 L4.53 Cr19.11 Cr
Operating Expenses 18.88 L16.42 L2.85 Cr16.05 Cr
Operating Income -18.88 L1.53 L1.68 Cr3.06 Cr
EBITDA -18.87 L1.52 L2.36 Cr4.26 Cr
Interest Expense 87,0001.65 L6.76 L40.25 L
Pretax Income -19.74 L-13,0002.11 Cr2.22 Cr
Tax Provision 3.52 L3.52 L27.33 L1.01 Cr
Net Income -23.26 L-3.65 L1.84 Cr1.21 Cr
Diluted EPS -1.35-0.210.110.01

Compounded Sales Growth

5 Years:-
1 Year:760.50%

Compounded Profit Growth

5 Years:206.43%
1 Year:-

Stock Price Performance

1 Year:-50.84%
6 Months:-11.32%
3 Months:-7.16%
1 Month:-1.78%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets 19.03 L35.35 L86.32 Cr457.37 Cr
Current Assets 4.93 L24.79 L70.41 Cr365.29 Cr
Cash & Equivalents 1.56 L3.58 L94.83 L104.26 Cr
Inventory -04.48 Cr9.16 Cr
Receivables 017.06 L22.87 Cr76.07 Cr
Total Liabilities 41.98 L61.95 L5.21 Cr119.50 Cr
Current Liabilities 41.98 L4.78 L3.83 Cr101.82 Cr
Long Term Debt 057.17 L026.25 L
Total Debt 38.92 L57.17 L1.68 Cr85.37 Cr
Total Equity -22.95 L-26.60 L81.11 Cr337.52 Cr
Shares Outstanding 1.72 L17.20 L5.35 Cr63.80 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow -17.69 L-14.59 L-7.35 Cr-86.74 Cr
Investing Cash Flow 00-31.39 Cr-124.88 Cr
Financing Cash Flow 14.76 L16.60 L37.06 Cr314.92 Cr
Capital Expenditure ---48.49 L-5.99 Cr
Free Cash Flow -17.69 L-14.59 L-7.84 Cr-92.73 Cr
Net Change in Cash -2.93 L2.01 L-1.68 Cr103.31 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Gross Margin % -100.0%21.6%17.3%
Operating Margin % -8.5%8.0%2.8%
Net Margin % --20.3%8.8%1.1%
ROE % 101.4%13.7%2.3%0.4%
ROCE % 82.3%5.0%2.0%0.9%

Shareholding Pattern

Insiders
76.28%
Institutions
2.55%
Public Float
10.73%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for FISCHER

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space